Skip to main content
Main navigation
People
Services
Insights
Trendscape
Publications
Podcast
Resources
M&A Explorer
Debt Explorer
US Administration Tracker
CFIUS FIRRMA Tool 2.0
Dawn Raid Analysis Quarterly
Non-Compete Resource Center (NCRC)
About Us
Our Firm
Locations
Responsible Business
Newsroom
Perspective: 2024
2024 Responsible Business Review
Former Partners
Careers
Careers
Apply
Inside White & Case
Alumni
Breadcrumb
Home
Insights
Publications & Events
Type
Alert
Event / Webinar
Our Thinking
Story
Service
AI Regulatory
Africa
Agency Finance
Antitrust litigation & class actions
Antitrust/Competition
Appellate Litigation
Artificial Intelligence (AI)
Asia-Pacific
Asset Finance
Australia
Aviation
Bank Lending
Battery Storage
Belgium
Belt and Road Initiative (BRI)
Borrower Finance
Brazil
Business & Human Rights
Canada
Capital Markets
Carbon capture, utilization and storage (CCUS)
Cartel investigations
Central & Eastern Europe
Chemicals
Competition compliance
Construction
Consumer & Retail
Content and non-privacy data regulation
Cybersecurity Advisory and Compliance
Czech Republic
Data, Privacy & Cybersecurity
Debt Finance
Derivatives
Drug Pricing
Due process
Economic Sanctions & Export Controls
Egypt
Employment, Compensation & Benefits
Energy
Energy Transition
Enforcement of Arbitral Awards & Judgments
Environment & Climate Change
European state aid
Financial Institutions
Financial Restructuring and Insolvency
Financial Services Regulatory
Finland
Fintech
Foreign Direct Investment (FDI) Reviews
Foreign Subsidies Regulation (FSR)
France
Fund Finance
Germany
Green LNG
Hong Kong SAR
Hydrogen
Incident Response
India
Indonesia
Infrastructure, Transportation & Logistics
Intellectual Property
International Arbitration
International Trade
Investment Funds
Islamic Finance
Israel
Italy
Japan
Kazakhstan
Korea
Latin America
Life Sciences and Healthcare
Litigation
Luxembourg
Mainland China
Maritime & Offshore
Media
Merger control
Mergers & Acquisitions
Mexico
Middle East
Mining & Metals
National Security
Nordic
North America
Nuclear Energy
Oman
Pharmaceutical antitrust litigation
Philippines
Poland
Power
Privacy Advisory and Compliance
Privacy and Cybersecurity Litigation
Private Capital
Private Credit & Direct Lending
Private Wealth & Family Offices
Pro Bono
Project Development and Finance
Qatar
Real Estate
Real Estate Finance
Regulatory & Compliance
Renewable Energy
Saudi Arabia
Securities Litigation & Regulatory Enforcement
Shareholder Activism
Singapore
South Africa
Sovereigns
Spain
Sports
Sustainability & Responsible Business
Sweden
Switzerland
Taiwan
Tax
Technology
Technology Transactions
Türkiye
UAE
US Government Contracts
US Public Company Advisory
United Kingdom
United States
Vietnam
Water
Western Europe
White Collar/Investigations
Region
Americas
EMEA
Asia-Pacific
Drug Pricing
Clear
Most Recent
Most Relevant
Most Recent
Most Relevant
Asc
Desc
6 results
Article
19 August 2024
United States: Pharmaceutical Antitrust 2025
Article
11 September 2023
United States: Pharmaceutical Antitrust 2024
Alert
20 December 2022
Five Drug Pricing Issues to Watch in 2023
Article
12 October 2022
United States: Pharmaceutical Antitrust 2023
Alert
14 September 2022
2022 Drug Pricing Update: States Continue Legislative Push Even As Congress Passes Long Sought Changes
Article
25 November 2021
Lexology GTDT: EU Antitrust Developments in the Pharmaceutical Sector
Search Dialog
×
×
Close
Share a link to this page
Email
LinkedIn
X
Facebook
